Engene Therapeutics Inc(ENGN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low1.8500
Day High1.9300
Open:1.9200
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: enGene Holdings (ENGN), Medtronic (MDT) and Roivant Sciences (ROIV)
Tipranks
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Intellia Therapeutics (NTLA)
Tipranks
enGene Restructures, Cuts Workforce to Advance Bladder Therapy
Tipranks
enGene Holdings Shareholders Approve Board and Auditor Slate
Motley Fool
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Motley Fool
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
Motley Fool
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
Tipranks
enGene Holdings (ENGN) Gets a Buy from H.C. Wainwright
MarketBeat
enGene Bladder Cancer Data Shows Promise, but Durability Questions Remain
MarketBeat.com
Tipranks
enGene Releases Mixed Interim Data from LEGEND Phase 2 Trial
Tipranks
Piper Sandler Sticks to Its Buy Rating for enGene Holdings (ENGN)
Tipranks
H.C. Wainwright Keeps Their Buy Rating on enGene Holdings (ENGN)
Tipranks
WBB Securities Initiates a Buy Rating on enGene Holdings (ENGN)
Tipranks
enGene Therapeutics Rebrands as Company Nears Commercialization
Tipranks
enGene Rebrands as enGene Therapeutics Ahead of Potential 2027 Commercial Launch
Tipranks
enGene Rebrands as enGene Therapeutics Ahead of Planned Bladder Cancer Gene Therapy Filing
Tipranks
Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Sanuwave Health (SNWV), enGene Holdings (ENGN)
Tipranks
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Boston Scientific (BSX)

Profile

enGene Holdings Inc. is a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues. enGene Holdings Inc., formerly known as Forbion European Acquisition Corp., is based in MONTREAL.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.